These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15232580)

  • 21. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells.
    Iglesias AH; Camelo S; Hwang D; Villanueva R; Stephanopoulos G; Dangond F
    J Neuroimmunol; 2004 May; 150(1-2):163-77. PubMed ID: 15081262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death.
    Li Z; Kreutzer M; Mikkat S; Mise N; Glocker MO; Pützer BM
    Proteomics; 2006 Nov; 6(21):5735-45. PubMed ID: 17001603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
    Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
    Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Runx3-/- gastric epithelial cells differentiate into intestinal type cells.
    Fukamachi H; Ito K; Ito Y
    Biochem Biophys Res Commun; 2004 Aug; 321(1):58-64. PubMed ID: 15358215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MBD2 deficiency does not accelerate p53 mediated lymphomagenesis.
    Sansom OJ; Bishop SM; Bird A; Clarke AR
    Oncogene; 2005 Mar; 24(14):2430-2. PubMed ID: 15735763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
    Campbell MR; Nation PN; Andrew SE
    Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells.
    Prost S; Lu P; Caldwell H; Harrison D
    Oncogene; 2007 May; 26(24):3572-81. PubMed ID: 17173070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 heterozygosity results in an increased 2-acetylaminofluorene-induced urinary bladder but not liver tumor response in DNA repair-deficient Xpa mice.
    Hoogervorst EM; van Oostrom CT; Beems RB; van Benthem J; Gielis S; Vermeulen JP; Wester PW; Vos JG; de Vries A; van Steeg H
    Cancer Res; 2004 Aug; 64(15):5118-26. PubMed ID: 15289314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumorigenic activity of p21Waf1/Cip1 in thymic lymphoma.
    De la Cueva E; García-Cao I; Herranz M; López P; García-Palencia P; Flores JM; Serrano M; Fernández-Piqueras J; Martín-Caballero J
    Oncogene; 2006 Jul; 25(29):4128-32. PubMed ID: 16462758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
    Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF
    Oncogene; 2007 Aug; 26(35):5086-97. PubMed ID: 17310987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dp1 is required for extra-embryonic development.
    Kohn MJ; Bronson RT; Harlow E; Dyson NJ; Yamasaki L
    Development; 2003 Apr; 130(7):1295-305. PubMed ID: 12588846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of illegitimate V(D)J recombination or microhomology-mediated nonhomologous end-joining in the formation of intragenic deletions of the Notch1 gene in mouse thymic lymphomas.
    Tsuji H; Ishii-Ohba H; Katsube T; Ukai H; Aizawa S; Doi M; Hioki K; Ogiu T
    Cancer Res; 2004 Dec; 64(24):8882-90. PubMed ID: 15604248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.
    McCabe MT; Davis JN; Day ML
    Cancer Res; 2005 May; 65(9):3624-32. PubMed ID: 15867357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequent retention of heterozygosity for point mutations in p53 and Ikaros in N-ethyl-N-nitrosourea-induced mouse thymic lymphomas.
    Kakinuma S; Nishimura M; Kubo A; Nagai JY; Amasaki Y; Majima HJ; Sado T; Shimada Y
    Mutat Res; 2005 May; 572(1-2):132-41. PubMed ID: 15790496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic instability in Gadd45a-deficient mice.
    Hollander MC; Sheikh MS; Bulavin DV; Lundgren K; Augeri-Henmueller L; Shehee R; Molinaro TA; Kim KE; Tolosa E; Ashwell JD; Rosenberg MP; Zhan Q; Fernández-Salguero PM; Morgan WF; Deng CX; Fornace AJ
    Nat Genet; 1999 Oct; 23(2):176-84. PubMed ID: 10508513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The yin and yang of E2F-1: balancing life and death.
    La Thangue NB
    Nat Cell Biol; 2003 Jul; 5(7):587-9. PubMed ID: 12833056
    [No Abstract]   [Full Text] [Related]  

  • 39. Mouse models with modified p53 sequences to study cancer and ageing.
    Clarke AR; Hollstein M
    Cell Death Differ; 2003 Apr; 10(4):443-50. PubMed ID: 12719721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of apoptosis by telomere 3' overhang-specific DNA.
    Eller MS; Puri N; Hadshiew IM; Venna SS; Gilchrest BA
    Exp Cell Res; 2002 Jun; 276(2):185-93. PubMed ID: 12027448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.